Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

I disagree as much was said. They are requesting FDA approval to start the first phase II trial in over a month.

The most important news is they allegedly fixed the supply problem and will have different suppliers for each version of Grb-2 with back ups. That is big IMO as it was the cause of all the dalays.

The drug appears to be effective so far.

Their pipeline now looks good.

If the FDA approve Phase II in Nov. the $20 prediction may happen in 12 months.

I await the ASH.